

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.74215124 |
| 2 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.46558373 |
| 3 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.41709909 |
| 4 | neuronal action potential propagation (GO:0019227) | 4.33447103 |
| 5 | regulation of cell communication by electrical coupling (GO:0010649) | 4.26513828 |
| 6 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.23444900 |
| 7 | respiratory electron transport chain (GO:0022904) | 4.12488884 |
| 8 | ATP synthesis coupled proton transport (GO:0015986) | 4.06083975 |
| 9 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.06083975 |
| 10 | electron transport chain (GO:0022900) | 4.05244586 |
| 11 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.98912475 |
| 12 | platelet dense granule organization (GO:0060155) | 3.98742798 |
| 13 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.98424036 |
| 14 | respiratory chain complex IV assembly (GO:0008535) | 3.89830522 |
| 15 | synaptic vesicle exocytosis (GO:0016079) | 3.73349340 |
| 16 | muscle filament sliding (GO:0030049) | 3.70987238 |
| 17 | actin-myosin filament sliding (GO:0033275) | 3.70987238 |
| 18 | DNA deamination (GO:0045006) | 3.62991968 |
| 19 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.59351523 |
| 20 | detection of calcium ion (GO:0005513) | 3.57363573 |
| 21 | neuron cell-cell adhesion (GO:0007158) | 3.55795675 |
| 22 | protein complex biogenesis (GO:0070271) | 3.49388805 |
| 23 | regulation of skeletal muscle contraction (GO:0014819) | 3.49290510 |
| 24 | proteasome assembly (GO:0043248) | 3.43442342 |
| 25 | cytochrome complex assembly (GO:0017004) | 3.42493531 |
| 26 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 3.39837256 |
| 27 | vocalization behavior (GO:0071625) | 3.38976154 |
| 28 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.36980557 |
| 29 | regulation of relaxation of muscle (GO:1901077) | 3.36238597 |
| 30 | skeletal muscle contraction (GO:0003009) | 3.35475718 |
| 31 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.32955416 |
| 32 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.32697166 |
| 33 | regulation of glucokinase activity (GO:0033131) | 3.30407781 |
| 34 | regulation of hexokinase activity (GO:1903299) | 3.30407781 |
| 35 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.28479984 |
| 36 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.27336437 |
| 37 | adaptation of signaling pathway (GO:0023058) | 3.24850439 |
| 38 | tricarboxylic acid cycle (GO:0006099) | 3.24785340 |
| 39 | regulation of coenzyme metabolic process (GO:0051196) | 3.23504482 |
| 40 | regulation of cofactor metabolic process (GO:0051193) | 3.23504482 |
| 41 | cytidine metabolic process (GO:0046087) | 3.22579588 |
| 42 | cytidine catabolic process (GO:0006216) | 3.22579588 |
| 43 | cytidine deamination (GO:0009972) | 3.22579588 |
| 44 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.22515477 |
| 45 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.22143645 |
| 46 | protein localization to synapse (GO:0035418) | 3.17579684 |
| 47 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.16472146 |
| 48 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.14958018 |
| 49 | mitochondrial respiratory chain complex assembly (GO:0033108) | 3.13761182 |
| 50 | regulation of synaptic vesicle transport (GO:1902803) | 3.08266878 |
| 51 | inositol phosphate catabolic process (GO:0071545) | 3.08114193 |
| 52 | adenosine metabolic process (GO:0046085) | 3.08114087 |
| 53 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.05274642 |
| 54 | actin-mediated cell contraction (GO:0070252) | 3.03472172 |
| 55 | glutamate secretion (GO:0014047) | 3.01603318 |
| 56 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 2.99267528 |
| 57 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.98980379 |
| 58 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.98980379 |
| 59 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 2.98398865 |
| 60 | NADH dehydrogenase complex assembly (GO:0010257) | 2.98398865 |
| 61 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 2.98398865 |
| 62 | sarcomere organization (GO:0045214) | 2.97062982 |
| 63 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.96121596 |
| 64 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.95820002 |
| 65 | protein K11-linked deubiquitination (GO:0035871) | 2.94814428 |
| 66 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.93830067 |
| 67 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.93327214 |
| 68 | succinate metabolic process (GO:0006105) | 2.93204879 |
| 69 | regulation of protein glycosylation (GO:0060049) | 2.90892465 |
| 70 | dopamine transport (GO:0015872) | 2.90399597 |
| 71 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.90257878 |
| 72 | cullin deneddylation (GO:0010388) | 2.89250533 |
| 73 | auditory receptor cell stereocilium organization (GO:0060088) | 2.86654180 |
| 74 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.84275726 |
| 75 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.84275726 |
| 76 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.82406656 |
| 77 | NADH metabolic process (GO:0006734) | 2.82024272 |
| 78 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 2.81972064 |
| 79 | keratinocyte development (GO:0003334) | 2.81599739 |
| 80 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.80178191 |
| 81 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.80178191 |
| 82 | DNA double-strand break processing (GO:0000729) | 2.78906194 |
| 83 | striated muscle contraction (GO:0006941) | 2.78731738 |
| 84 | positive regulation of mitochondrial fission (GO:0090141) | 2.78160024 |
| 85 | glycogen catabolic process (GO:0005980) | 2.77850854 |
| 86 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.77789444 |
| 87 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.75970225 |
| 88 | signal peptide processing (GO:0006465) | 2.75660691 |
| 89 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.74850657 |
| 90 | phosphorylated carbohydrate dephosphorylation (GO:0046838) | 2.73136343 |
| 91 | inositol phosphate dephosphorylation (GO:0046855) | 2.73136343 |
| 92 | negative regulation of cation channel activity (GO:2001258) | 2.72861902 |
| 93 | protein targeting to Golgi (GO:0000042) | 2.72648453 |
| 94 | oxidative phosphorylation (GO:0006119) | 2.72155232 |
| 95 | presynaptic membrane assembly (GO:0097105) | 2.71921204 |
| 96 | regulation of membrane repolarization (GO:0060306) | 2.71539442 |
| 97 | protein localization to cilium (GO:0061512) | 2.70717510 |
| 98 | xenobiotic catabolic process (GO:0042178) | 2.68965469 |
| 99 | mannosylation (GO:0097502) | 2.68430979 |
| 100 | plasma membrane repair (GO:0001778) | 2.67360108 |
| 101 | membrane depolarization during action potential (GO:0086010) | 2.66239732 |
| 102 | anterograde synaptic vesicle transport (GO:0048490) | 2.65894681 |
| 103 | establishment of protein localization to Golgi (GO:0072600) | 2.65417578 |
| 104 | neurotransmitter secretion (GO:0007269) | 2.65275497 |
| 105 | response to pheromone (GO:0019236) | 2.64697704 |
| 106 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.64261950 |
| 107 | oxygen transport (GO:0015671) | 2.63882103 |
| 108 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.63387863 |
| 109 | cardiac muscle contraction (GO:0060048) | 2.63239183 |
| 110 | protein deneddylation (GO:0000338) | 2.62229801 |
| 111 | neuromuscular synaptic transmission (GO:0007274) | 2.62189900 |
| 112 | neural tube formation (GO:0001841) | 2.62008415 |
| 113 | inner mitochondrial membrane organization (GO:0007007) | 2.60490371 |
| 114 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.60243940 |
| 115 | polyol catabolic process (GO:0046174) | 2.57000164 |
| 116 | negative regulation of membrane potential (GO:0045837) | 2.56678835 |
| 117 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.56375909 |
| 118 | glucan catabolic process (GO:0009251) | 2.53423778 |
| 119 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.53098691 |
| 120 | transferrin transport (GO:0033572) | 2.52774301 |
| 121 | hydrogen ion transmembrane transport (GO:1902600) | 2.51377422 |
| 122 | regulation of sulfur metabolic process (GO:0042762) | 2.50251137 |
| 123 | regulation of actin filament-based movement (GO:1903115) | 2.49078849 |
| 124 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.49074857 |
| 125 | positive regulation of glycolytic process (GO:0045821) | 2.48316841 |
| 126 | myofibril assembly (GO:0030239) | 2.48063917 |
| 127 | cellular ketone body metabolic process (GO:0046950) | 2.47451993 |
| 128 | fucose catabolic process (GO:0019317) | 2.47060475 |
| 129 | L-fucose metabolic process (GO:0042354) | 2.47060475 |
| 130 | L-fucose catabolic process (GO:0042355) | 2.47060475 |
| 131 | negative regulation of ion transmembrane transporter activity (GO:0032413) | 2.46530232 |
| 132 | regulation of sarcomere organization (GO:0060297) | 2.46440984 |
| 133 | neuron recognition (GO:0008038) | 2.45548921 |
| 134 | protein neddylation (GO:0045116) | 2.45352642 |
| 135 | regulation of memory T cell differentiation (GO:0043380) | 2.44872667 |
| 136 | regulation of cation channel activity (GO:2001257) | 2.44241302 |
| 137 | regulation of oxidative phosphorylation (GO:0002082) | 2.43724561 |
| 138 | striatum development (GO:0021756) | 2.43668559 |
| 139 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.43131047 |
| 140 | regulation of striated muscle contraction (GO:0006942) | 2.42804299 |
| 141 | negative regulation of heart rate (GO:0010459) | 2.42448593 |
| 142 | female mating behavior (GO:0060180) | 2.42017691 |
| 143 | inner ear receptor stereocilium organization (GO:0060122) | 2.41719658 |
| 144 | presynaptic membrane organization (GO:0097090) | 2.41137990 |
| 145 | ATP biosynthetic process (GO:0006754) | 2.40642019 |
| 146 | postsynaptic membrane organization (GO:0001941) | 2.40086851 |
| 147 | neuron-neuron synaptic transmission (GO:0007270) | 2.39763699 |
| 148 | regulation of vesicle fusion (GO:0031338) | 2.39683299 |
| 149 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.39512116 |
| 150 | regulation of synapse structural plasticity (GO:0051823) | 2.39440396 |
| 151 | piRNA metabolic process (GO:0034587) | 2.39093976 |
| 152 | nucleotide transmembrane transport (GO:1901679) | 2.37932813 |
| 153 | RNA destabilization (GO:0050779) | 2.34268577 |
| 154 | S-adenosylmethionine metabolic process (GO:0046500) | 2.33641963 |
| 155 | protein-cofactor linkage (GO:0018065) | 2.32025190 |
| 156 | ketone body metabolic process (GO:1902224) | 2.31671902 |
| 157 | prenylation (GO:0097354) | 2.31335321 |
| 158 | protein prenylation (GO:0018342) | 2.31335321 |
| 159 | protein localization to Golgi apparatus (GO:0034067) | 2.30918333 |
| 160 | negative regulation of telomere maintenance (GO:0032205) | 2.30456403 |
| 161 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.29735666 |
| 162 | preassembly of GPI anchor in ER membrane (GO:0016254) | 2.25538940 |
| 163 | behavioral response to nicotine (GO:0035095) | 2.24522173 |
| 164 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 2.22453182 |
| 165 | indolalkylamine metabolic process (GO:0006586) | 2.22288149 |
| 166 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 2.21182325 |
| 167 | heart contraction (GO:0060047) | 2.19482544 |
| 168 | heart process (GO:0003015) | 2.19482544 |
| 169 | nonmotile primary cilium assembly (GO:0035058) | 2.18736524 |
| 170 | lactate metabolic process (GO:0006089) | 2.18395526 |
| 171 | magnesium ion transport (GO:0015693) | 2.18337209 |
| 172 | negative regulation of protein autophosphorylation (GO:0031953) | 2.18071856 |
| 173 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.17417433 |
| 174 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.17315106 |
| 175 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.17315106 |
| 176 | cornea development in camera-type eye (GO:0061303) | 2.17152717 |
| 177 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.17098868 |
| 178 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.16131655 |
| 179 | detection of light stimulus involved in visual perception (GO:0050908) | 2.16131655 |
| 180 | ubiquinone biosynthetic process (GO:0006744) | 2.15851029 |
| 181 | amine catabolic process (GO:0009310) | 2.15848731 |
| 182 | cellular biogenic amine catabolic process (GO:0042402) | 2.15848731 |
| 183 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.15299628 |
| 184 | regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211) | 2.14459405 |
| 185 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213) | 2.14459405 |
| 186 | photoreceptor cell maintenance (GO:0045494) | 2.11743542 |
| 187 | positive regulation of protein autophosphorylation (GO:0031954) | 2.11108245 |
| 188 | purine-containing compound salvage (GO:0043101) | 2.10770080 |
| 189 | regulation of neurotransmitter uptake (GO:0051580) | 2.10405425 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.61774072 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.12414036 |
| 3 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.68595607 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.67235258 |
| 5 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.60256691 |
| 6 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.52427479 |
| 7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.39966466 |
| 8 | VDR_22108803_ChIP-Seq_LS180_Human | 2.36430871 |
| 9 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.33960363 |
| 10 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.32332901 |
| 11 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.29597586 |
| 12 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.16356323 |
| 13 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.15468459 |
| 14 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.14721085 |
| 15 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.11432283 |
| 16 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.11432283 |
| 17 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.05991091 |
| 18 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.05668161 |
| 19 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.05070407 |
| 20 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.04743649 |
| 21 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.04436735 |
| 22 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 2.03591169 |
| 23 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.96529852 |
| 24 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.96186723 |
| 25 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.96113722 |
| 26 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.92216150 |
| 27 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.91625618 |
| 28 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.90391500 |
| 29 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.87993800 |
| 30 | EWS_26573619_Chip-Seq_HEK293_Human | 1.86458345 |
| 31 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.85596662 |
| 32 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.84237915 |
| 33 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.77965650 |
| 34 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.77151876 |
| 35 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.75002759 |
| 36 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.73743984 |
| 37 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.72527241 |
| 38 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.68167582 |
| 39 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.67691845 |
| 40 | * HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.65575375 |
| 41 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.63871745 |
| 42 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.63601990 |
| 43 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.63397727 |
| 44 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.63179847 |
| 45 | P300_19829295_ChIP-Seq_ESCs_Human | 1.62911263 |
| 46 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.61782629 |
| 47 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.60370512 |
| 48 | * ELK1_19687146_ChIP-ChIP_HELA_Human | 1.60336512 |
| 49 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.58122489 |
| 50 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.57751601 |
| 51 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.54519696 |
| 52 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.53329075 |
| 53 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.53069014 |
| 54 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.52517838 |
| 55 | FUS_26573619_Chip-Seq_HEK293_Human | 1.48110739 |
| 56 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.48039344 |
| 57 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.46148269 |
| 58 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.46132378 |
| 59 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.44188414 |
| 60 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.43899566 |
| 61 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.43899566 |
| 62 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.43035768 |
| 63 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.42817026 |
| 64 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.40505299 |
| 65 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.39377076 |
| 66 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.38654532 |
| 67 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.38478873 |
| 68 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.38370399 |
| 69 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.37819866 |
| 70 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.34876732 |
| 71 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.34789892 |
| 72 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.33369036 |
| 73 | AR_25329375_ChIP-Seq_VCAP_Human | 1.33342975 |
| 74 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.32840340 |
| 75 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.32260670 |
| 76 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.32166830 |
| 77 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.31754663 |
| 78 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.31464003 |
| 79 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.30934153 |
| 80 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.28686702 |
| 81 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.28676569 |
| 82 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.28173461 |
| 83 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.23488102 |
| 84 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.23286140 |
| 85 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.23198058 |
| 86 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.23003722 |
| 87 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.22705149 |
| 88 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.20682230 |
| 89 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.20126074 |
| 90 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.19276267 |
| 91 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.18622191 |
| 92 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.18284791 |
| 93 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.18182813 |
| 94 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.18182813 |
| 95 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.17526938 |
| 96 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.17334128 |
| 97 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.17136326 |
| 98 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.16645323 |
| 99 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.16058798 |
| 100 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.15173975 |
| 101 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.14093156 |
| 102 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.13147546 |
| 103 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.12760627 |
| 104 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.12435384 |
| 105 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.12188303 |
| 106 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.11922334 |
| 107 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.09459524 |
| 108 | GATA3_26560356_Chip-Seq_TH2_Human | 1.09089800 |
| 109 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08395521 |
| 110 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08288777 |
| 111 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 1.07587097 |
| 112 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.07090157 |
| 113 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06438167 |
| 114 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.04249713 |
| 115 | AR_20517297_ChIP-Seq_VCAP_Human | 1.03823659 |
| 116 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.01959756 |
| 117 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.01426534 |
| 118 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.99316415 |
| 119 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.97070773 |
| 120 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.96229678 |
| 121 | * GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.95800810 |
| 122 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.95710556 |
| 123 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.93637333 |
| 124 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.93628602 |
| 125 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.93599737 |
| 126 | STAT3_23295773_ChIP-Seq_U87_Human | 0.93541872 |
| 127 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.92326525 |
| 128 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.91934541 |
| 129 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.91760570 |
| 130 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.88646705 |
| 131 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.88136650 |
| 132 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.87590617 |
| 133 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.87590617 |
| 134 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.87582750 |
| 135 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.87307911 |
| 136 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.86849686 |
| 137 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.86774065 |
| 138 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.86367946 |
| 139 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.86274375 |
| 140 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.86164410 |
| 141 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.84150958 |
| 142 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.83739648 |
| 143 | TCF4_23295773_ChIP-Seq_U87_Human | 0.83735185 |
| 144 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.83087119 |
| 145 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.82790927 |
| 146 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.82790927 |
| 147 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.81547290 |
| 148 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.81324538 |
| 149 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.81143059 |
| 150 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.80883462 |
| 151 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.80350148 |
| 152 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.80015769 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 4.10297430 |
| 2 | MP0003646_muscle_fatigue | 3.67911849 |
| 3 | MP0003880_abnormal_central_pattern | 3.56335648 |
| 4 | MP0004145_abnormal_muscle_electrophysio | 3.54447058 |
| 5 | MP0000751_myopathy | 3.46283516 |
| 6 | MP0004859_abnormal_synaptic_plasticity | 2.97127647 |
| 7 | MP0004270_analgesia | 2.93191170 |
| 8 | MP0000749_muscle_degeneration | 2.80184251 |
| 9 | MP0002822_catalepsy | 2.76814854 |
| 10 | MP0006276_abnormal_autonomic_nervous | 2.58102130 |
| 11 | MP0003635_abnormal_synaptic_transmissio | 2.47948485 |
| 12 | MP0004036_abnormal_muscle_relaxation | 2.41400053 |
| 13 | MP0003724_increased_susceptibility_to | 2.33278407 |
| 14 | MP0008877_abnormal_DNA_methylation | 2.32616978 |
| 15 | MP0000372_irregular_coat_pigmentation | 2.31276830 |
| 16 | MP0002734_abnormal_mechanical_nocicepti | 2.23507738 |
| 17 | MP0002102_abnormal_ear_morphology | 2.21557512 |
| 18 | MP0009745_abnormal_behavioral_response | 2.20078753 |
| 19 | MP0001968_abnormal_touch/_nociception | 2.17933502 |
| 20 | MP0002735_abnormal_chemical_nociception | 2.17921411 |
| 21 | MP0004215_abnormal_myocardial_fiber | 2.15998778 |
| 22 | MP0002277_abnormal_respiratory_mucosa | 2.11228626 |
| 23 | MP0002063_abnormal_learning/memory/cond | 2.06086428 |
| 24 | MP0000569_abnormal_digit_pigmentation | 2.04470329 |
| 25 | MP0002064_seizures | 2.04101476 |
| 26 | MP0009046_muscle_twitch | 1.95080331 |
| 27 | MP0004147_increased_porphyrin_level | 1.92864320 |
| 28 | MP0002572_abnormal_emotion/affect_behav | 1.89618241 |
| 29 | MP0002272_abnormal_nervous_system | 1.89298880 |
| 30 | MP0000747_muscle_weakness | 1.86192292 |
| 31 | MP0004130_abnormal_muscle_cell | 1.84577698 |
| 32 | MP0002733_abnormal_thermal_nociception | 1.83923637 |
| 33 | MP0004484_altered_response_of | 1.82441561 |
| 34 | MP0000013_abnormal_adipose_tissue | 1.81370312 |
| 35 | MP0002106_abnormal_muscle_physiology | 1.80712485 |
| 36 | MP0005620_abnormal_muscle_contractility | 1.80316603 |
| 37 | MP0001970_abnormal_pain_threshold | 1.79965399 |
| 38 | MP0001440_abnormal_grooming_behavior | 1.78210494 |
| 39 | MP0002736_abnormal_nociception_after | 1.78059216 |
| 40 | MP0001529_abnormal_vocalization | 1.77304575 |
| 41 | MP0005084_abnormal_gallbladder_morpholo | 1.76167368 |
| 42 | MP0001984_abnormal_olfaction | 1.73366285 |
| 43 | MP0005551_abnormal_eye_electrophysiolog | 1.72034907 |
| 44 | MP0001501_abnormal_sleep_pattern | 1.71063070 |
| 45 | MP0006036_abnormal_mitochondrial_physio | 1.65574076 |
| 46 | MP0003806_abnormal_nucleotide_metabolis | 1.65289224 |
| 47 | MP0004233_abnormal_muscle_weight | 1.59805692 |
| 48 | MP0003011_delayed_dark_adaptation | 1.58946959 |
| 49 | MP0005645_abnormal_hypothalamus_physiol | 1.58835490 |
| 50 | MP0004084_abnormal_cardiac_muscle | 1.57094505 |
| 51 | MP0002163_abnormal_gland_morphology | 1.56840753 |
| 52 | MP0002067_abnormal_sensory_capabilities | 1.53995547 |
| 53 | MP0000759_abnormal_skeletal_muscle | 1.53519187 |
| 54 | MP0005369_muscle_phenotype | 1.53076912 |
| 55 | MP0005075_abnormal_melanosome_morpholog | 1.52219409 |
| 56 | MP0005330_cardiomyopathy | 1.50482330 |
| 57 | MP0003186_abnormal_redox_activity | 1.45987978 |
| 58 | MP0005253_abnormal_eye_physiology | 1.43926827 |
| 59 | MP0002184_abnormal_innervation | 1.43639599 |
| 60 | MP0004087_abnormal_muscle_fiber | 1.43032637 |
| 61 | MP0002269_muscular_atrophy | 1.42939382 |
| 62 | MP0005174_abnormal_tail_pigmentation | 1.42802655 |
| 63 | MP0008872_abnormal_physiological_respon | 1.42202273 |
| 64 | MP0002909_abnormal_adrenal_gland | 1.41566818 |
| 65 | MP0009785_altered_susceptibility_to | 1.41307619 |
| 66 | MP0003122_maternal_imprinting | 1.40305942 |
| 67 | MP0004924_abnormal_behavior | 1.39027800 |
| 68 | MP0005386_behavior/neurological_phenoty | 1.39027800 |
| 69 | MP0004085_abnormal_heartbeat | 1.38455895 |
| 70 | MP0002148_abnormal_hypersensitivity_rea | 1.37370023 |
| 71 | MP0002332_abnormal_exercise_endurance | 1.37178583 |
| 72 | MP0002972_abnormal_cardiac_muscle | 1.35633623 |
| 73 | MP0004142_abnormal_muscle_tone | 1.35097939 |
| 74 | MP0009780_abnormal_chondrocyte_physiolo | 1.32947539 |
| 75 | MP0003137_abnormal_impulse_conducting | 1.32018819 |
| 76 | MP0001486_abnormal_startle_reflex | 1.31832230 |
| 77 | MP0005646_abnormal_pituitary_gland | 1.28639085 |
| 78 | MP0002138_abnormal_hepatobiliary_system | 1.26618358 |
| 79 | MP0001905_abnormal_dopamine_level | 1.26347899 |
| 80 | MP0005671_abnormal_response_to | 1.26331601 |
| 81 | MP0000015_abnormal_ear_pigmentation | 1.25990279 |
| 82 | MP0001502_abnormal_circadian_rhythm | 1.18559179 |
| 83 | MP0004885_abnormal_endolymph | 1.18532120 |
| 84 | MP0000427_abnormal_hair_cycle | 1.17479406 |
| 85 | MP0005379_endocrine/exocrine_gland_phen | 1.16768846 |
| 86 | MP0002557_abnormal_social/conspecific_i | 1.12291850 |
| 87 | MP0002693_abnormal_pancreas_physiology | 1.10941264 |
| 88 | MP0009764_decreased_sensitivity_to | 1.10682861 |
| 89 | MP0000778_abnormal_nervous_system | 1.08803171 |
| 90 | MP0003786_premature_aging | 1.06588532 |
| 91 | MP0006054_spinal_hemorrhage | 1.05223444 |
| 92 | MP0005167_abnormal_blood-brain_barrier | 1.05034279 |
| 93 | MP0006072_abnormal_retinal_apoptosis | 1.04049343 |
| 94 | MP0008569_lethality_at_weaning | 1.04024105 |
| 95 | MP0003329_amyloid_beta_deposits | 1.03272143 |
| 96 | MP0002066_abnormal_motor_capabilities/c | 1.03127105 |
| 97 | MP0001919_abnormal_reproductive_system | 1.01127408 |
| 98 | MP0002638_abnormal_pupillary_reflex | 0.99973751 |
| 99 | MP0001986_abnormal_taste_sensitivity | 0.99224591 |
| 100 | MP0000750_abnormal_muscle_regeneration | 0.98926175 |
| 101 | MP0003656_abnormal_erythrocyte_physiolo | 0.98845681 |
| 102 | MP0005535_abnormal_body_temperature | 0.96547783 |
| 103 | MP0001835_abnormal_antigen_presentation | 0.96136493 |
| 104 | MP0006082_CNS_inflammation | 0.96003296 |
| 105 | MP0005389_reproductive_system_phenotype | 0.94213590 |
| 106 | MP0001188_hyperpigmentation | 0.94014503 |
| 107 | MP0000955_abnormal_spinal_cord | 0.93366440 |
| 108 | MP0004043_abnormal_pH_regulation | 0.93322862 |
| 109 | MP0008775_abnormal_heart_ventricle | 0.92883059 |
| 110 | MP0005332_abnormal_amino_acid | 0.92654855 |
| 111 | MP0003879_abnormal_hair_cell | 0.90545104 |
| 112 | MP0005423_abnormal_somatic_nervous | 0.90526439 |
| 113 | MP0003950_abnormal_plasma_membrane | 0.90123202 |
| 114 | MP0004811_abnormal_neuron_physiology | 0.89377009 |
| 115 | MP0006035_abnormal_mitochondrial_morpho | 0.87607121 |
| 116 | MP0001764_abnormal_homeostasis | 0.87340597 |
| 117 | MP0002095_abnormal_skin_pigmentation | 0.87169995 |
| 118 | MP0002882_abnormal_neuron_morphology | 0.85898386 |
| 119 | MP0005636_abnormal_mineral_homeostasis | 0.84112135 |
| 120 | MP0003221_abnormal_cardiomyocyte_apopto | 0.83421994 |
| 121 | MP0005266_abnormal_metabolism | 0.82270516 |
| 122 | MP0008875_abnormal_xenobiotic_pharmacok | 0.82101262 |
| 123 | MP0005387_immune_system_phenotype | 0.81587818 |
| 124 | MP0001790_abnormal_immune_system | 0.81587818 |
| 125 | MP0005385_cardiovascular_system_phenoty | 0.81057841 |
| 126 | MP0001544_abnormal_cardiovascular_syste | 0.81057841 |
| 127 | MP0005410_abnormal_fertilization | 0.81014713 |
| 128 | MP0003633_abnormal_nervous_system | 0.80475390 |
| 129 | MP0001756_abnormal_urination | 0.78825329 |
| 130 | MP0002090_abnormal_vision | 0.78237696 |
| 131 | MP0009697_abnormal_copulation | 0.78173605 |
| 132 | MP0000685_abnormal_immune_system | 0.78101606 |
| 133 | MP0003121_genomic_imprinting | 0.77812603 |
| 134 | MP0002108_abnormal_muscle_morphology | 0.76892973 |
| 135 | MP0003195_calcinosis | 0.76880715 |
| 136 | MP0004742_abnormal_vestibular_system | 0.76590940 |
| 137 | MP0005000_abnormal_immune_tolerance | 0.75839177 |
| 138 | MP0000230_abnormal_systemic_arterial | 0.73426177 |
| 139 | MP0001485_abnormal_pinna_reflex | 0.69628631 |
| 140 | MP0002876_abnormal_thyroid_physiology | 0.69323331 |
| 141 | MP0010386_abnormal_urinary_bladder | 0.69023129 |
| 142 | MP0006138_congestive_heart_failure | 0.67865949 |
| 143 | MP0003787_abnormal_imprinting | 0.65828420 |
| 144 | MP0002069_abnormal_eating/drinking_beha | 0.64453099 |
| 145 | MP0002751_abnormal_autonomic_nervous | 0.64113699 |
| 146 | MP0002234_abnormal_pharynx_morphology | 0.63705000 |
| 147 | MP0008874_decreased_physiological_sensi | 0.63579058 |
| 148 | MP0002078_abnormal_glucose_homeostasis | 0.62463952 |
| 149 | MP0008995_early_reproductive_senescence | 0.59717328 |
| 150 | MP0002752_abnormal_somatic_nervous | 0.58132090 |
| 151 | MP0000631_abnormal_neuroendocrine_gland | 0.57944758 |
| 152 | MP0009250_abnormal_appendicular_skeleto | 0.55342423 |
| 153 | MP0002971_abnormal_brown_adipose | 0.54758796 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 5.81540008 |
| 2 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.69465158 |
| 3 | Focal motor seizures (HP:0011153) | 4.42751071 |
| 4 | Acute necrotizing encephalopathy (HP:0006965) | 4.39203667 |
| 5 | Calf muscle hypertrophy (HP:0008981) | 4.36364082 |
| 6 | Exercise-induced muscle cramps (HP:0003710) | 4.32802913 |
| 7 | Muscle fiber inclusion bodies (HP:0100299) | 4.20562123 |
| 8 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.14861144 |
| 9 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.00818680 |
| 10 | Pheochromocytoma (HP:0002666) | 3.84250739 |
| 11 | Progressive macrocephaly (HP:0004481) | 3.82466185 |
| 12 | Nemaline bodies (HP:0003798) | 3.78889485 |
| 13 | Atonic seizures (HP:0010819) | 3.70769896 |
| 14 | Neuroendocrine neoplasm (HP:0100634) | 3.65826633 |
| 15 | Acute encephalopathy (HP:0006846) | 3.57561911 |
| 16 | Myotonia (HP:0002486) | 3.43899597 |
| 17 | Sudden death (HP:0001699) | 3.38089520 |
| 18 | Stomatitis (HP:0010280) | 3.35780022 |
| 19 | Abnormality of the calf musculature (HP:0001430) | 3.33230572 |
| 20 | Mitochondrial inheritance (HP:0001427) | 3.31098077 |
| 21 | Myoglobinuria (HP:0002913) | 3.26448855 |
| 22 | Distal arthrogryposis (HP:0005684) | 3.20968091 |
| 23 | Methylmalonic acidemia (HP:0002912) | 3.18461649 |
| 24 | Muscle fiber splitting (HP:0003555) | 3.16630896 |
| 25 | Myokymia (HP:0002411) | 3.04896790 |
| 26 | Febrile seizures (HP:0002373) | 2.90246990 |
| 27 | Pancreatic cysts (HP:0001737) | 2.87664787 |
| 28 | Congenital, generalized hypertrichosis (HP:0004540) | 2.85941298 |
| 29 | Muscle stiffness (HP:0003552) | 2.84658638 |
| 30 | Epileptic encephalopathy (HP:0200134) | 2.84383296 |
| 31 | Abnormality of the renal cortex (HP:0011035) | 2.83431941 |
| 32 | Increased CSF lactate (HP:0002490) | 2.82710667 |
| 33 | EMG: myopathic abnormalities (HP:0003458) | 2.80969530 |
| 34 | Congenital sensorineural hearing impairment (HP:0008527) | 2.79021792 |
| 35 | Hyporeflexia of lower limbs (HP:0002600) | 2.77357424 |
| 36 | Absence seizures (HP:0002121) | 2.72109849 |
| 37 | 3-Methylglutaconic aciduria (HP:0003535) | 2.70072287 |
| 38 | Type 1 muscle fiber predominance (HP:0003803) | 2.68613712 |
| 39 | Visual hallucinations (HP:0002367) | 2.62077565 |
| 40 | Pancreatic fibrosis (HP:0100732) | 2.62076646 |
| 41 | Congenital stationary night blindness (HP:0007642) | 2.60938055 |
| 42 | Hyperventilation (HP:0002883) | 2.60781969 |
| 43 | Hepatocellular necrosis (HP:0001404) | 2.57287404 |
| 44 | Molar tooth sign on MRI (HP:0002419) | 2.57131454 |
| 45 | Abnormality of midbrain morphology (HP:0002418) | 2.57131454 |
| 46 | Oligomenorrhea (HP:0000876) | 2.56406307 |
| 47 | Exercise intolerance (HP:0003546) | 2.54964464 |
| 48 | Palpitations (HP:0001962) | 2.54656740 |
| 49 | Cerebral edema (HP:0002181) | 2.52997455 |
| 50 | Rimmed vacuoles (HP:0003805) | 2.49834802 |
| 51 | Focal seizures (HP:0007359) | 2.49791585 |
| 52 | Renal cortical cysts (HP:0000803) | 2.49041960 |
| 53 | Gait imbalance (HP:0002141) | 2.46687107 |
| 54 | True hermaphroditism (HP:0010459) | 2.44303457 |
| 55 | Myopathic facies (HP:0002058) | 2.43616355 |
| 56 | Exertional dyspnea (HP:0002875) | 2.42921928 |
| 57 | Methylmalonic aciduria (HP:0012120) | 2.42722007 |
| 58 | Metaphyseal dysplasia (HP:0100255) | 2.38846196 |
| 59 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.38333526 |
| 60 | Hypothermia (HP:0002045) | 2.38198570 |
| 61 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.36905028 |
| 62 | Abnormality of alanine metabolism (HP:0010916) | 2.36905028 |
| 63 | Hyperalaninemia (HP:0003348) | 2.36905028 |
| 64 | Dialeptic seizures (HP:0011146) | 2.33732064 |
| 65 | Hypochromic microcytic anemia (HP:0004840) | 2.33253695 |
| 66 | Left ventricular hypertrophy (HP:0001712) | 2.33224832 |
| 67 | Hepatic necrosis (HP:0002605) | 2.32552518 |
| 68 | Congenital primary aphakia (HP:0007707) | 2.32327186 |
| 69 | Optic disc pallor (HP:0000543) | 2.31907412 |
| 70 | Shoulder girdle muscle weakness (HP:0003547) | 2.30887819 |
| 71 | Abnormality of vitamin B metabolism (HP:0004340) | 2.26442589 |
| 72 | Medial flaring of the eyebrow (HP:0010747) | 2.26348704 |
| 73 | Difficulty running (HP:0009046) | 2.25782349 |
| 74 | Nephronophthisis (HP:0000090) | 2.25222689 |
| 75 | Absent phalangeal crease (HP:0006109) | 2.24957925 |
| 76 | Generalized tonic-clonic seizures (HP:0002069) | 2.24253035 |
| 77 | Thyroiditis (HP:0100646) | 2.23916392 |
| 78 | Lactic acidosis (HP:0003128) | 2.23162933 |
| 79 | Neck muscle weakness (HP:0000467) | 2.21430690 |
| 80 | Round ear (HP:0100830) | 2.19301141 |
| 81 | Increased intramyocellular lipid droplets (HP:0012240) | 2.17406588 |
| 82 | Areflexia of lower limbs (HP:0002522) | 2.17034538 |
| 83 | Rhabdomyolysis (HP:0003201) | 2.16055762 |
| 84 | Anxiety (HP:0000739) | 2.13262111 |
| 85 | Renal Fanconi syndrome (HP:0001994) | 2.12917983 |
| 86 | Broad-based gait (HP:0002136) | 2.12327504 |
| 87 | Syncope (HP:0001279) | 2.10633576 |
| 88 | Abnormal ciliary motility (HP:0012262) | 2.10226725 |
| 89 | Abnormality of the renal medulla (HP:0100957) | 2.10141240 |
| 90 | Progressive inability to walk (HP:0002505) | 2.07014217 |
| 91 | Fetal akinesia sequence (HP:0001989) | 2.04597021 |
| 92 | Albinism (HP:0001022) | 2.04587544 |
| 93 | Increased muscle lipid content (HP:0009058) | 2.04388708 |
| 94 | Abnormality of urine glucose concentration (HP:0011016) | 2.02241241 |
| 95 | Glycosuria (HP:0003076) | 2.02241241 |
| 96 | Polydipsia (HP:0001959) | 2.01814189 |
| 97 | Abnormal drinking behavior (HP:0030082) | 2.01814189 |
| 98 | Respiratory failure (HP:0002878) | 1.99601096 |
| 99 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.99373943 |
| 100 | Abnormality of glycolysis (HP:0004366) | 1.97301950 |
| 101 | Increased serum pyruvate (HP:0003542) | 1.97301950 |
| 102 | Hypoglycemic coma (HP:0001325) | 1.97287641 |
| 103 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.97062417 |
| 104 | Large for gestational age (HP:0001520) | 1.96408612 |
| 105 | Nephrogenic diabetes insipidus (HP:0009806) | 1.96061312 |
| 106 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.93869050 |
| 107 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.93619244 |
| 108 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.93619244 |
| 109 | Ketosis (HP:0001946) | 1.93213222 |
| 110 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.91826148 |
| 111 | X-linked dominant inheritance (HP:0001423) | 1.90805449 |
| 112 | Abnormal finger flexion creases (HP:0006143) | 1.90326595 |
| 113 | Ketoacidosis (HP:0001993) | 1.90275504 |
| 114 | Abnormality of renal resorption (HP:0011038) | 1.88576374 |
| 115 | Prolonged QT interval (HP:0001657) | 1.87840618 |
| 116 | Asymmetric septal hypertrophy (HP:0001670) | 1.87208878 |
| 117 | Progressive cerebellar ataxia (HP:0002073) | 1.87106705 |
| 118 | Increased serum lactate (HP:0002151) | 1.86748623 |
| 119 | Genital tract atresia (HP:0001827) | 1.85948588 |
| 120 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.85919363 |
| 121 | Increased hepatocellular lipid droplets (HP:0006565) | 1.85463642 |
| 122 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.85057768 |
| 123 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.85057768 |
| 124 | Abnormality of macular pigmentation (HP:0008002) | 1.84856441 |
| 125 | Vaginal atresia (HP:0000148) | 1.84842284 |
| 126 | Leukodystrophy (HP:0002415) | 1.84813558 |
| 127 | Primary atrial arrhythmia (HP:0001692) | 1.84776014 |
| 128 | Abnormal hair whorl (HP:0010721) | 1.84610317 |
| 129 | Atrial fibrillation (HP:0005110) | 1.83930742 |
| 130 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.83915691 |
| 131 | Subaortic stenosis (HP:0001682) | 1.83915691 |
| 132 | Tongue fasciculations (HP:0001308) | 1.83622034 |
| 133 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.82917175 |
| 134 | Hypoplasia of the fovea (HP:0007750) | 1.82917175 |
| 135 | Conjunctival hamartoma (HP:0100780) | 1.82420179 |
| 136 | Fair hair (HP:0002286) | 1.82389670 |
| 137 | Ulnar deviation of the wrist (HP:0003049) | 1.82015477 |
| 138 | Lethargy (HP:0001254) | 1.81343573 |
| 139 | Lipid accumulation in hepatocytes (HP:0006561) | 1.80390878 |
| 140 | Muscle fibrillation (HP:0010546) | 1.79511775 |
| 141 | Poor suck (HP:0002033) | 1.79001613 |
| 142 | Increased variability in muscle fiber diameter (HP:0003557) | 1.78836543 |
| 143 | Disproportionate short-trunk short stature (HP:0003521) | 1.78469251 |
| 144 | Failure to thrive in infancy (HP:0001531) | 1.78281143 |
| 145 | Alveolar cell carcinoma (HP:0006519) | 1.77494089 |
| 146 | Hypoproteinemia (HP:0003075) | 1.76628631 |
| 147 | Furrowed tongue (HP:0000221) | 1.75309996 |
| 148 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.74499338 |
| 149 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.74429687 |
| 150 | Type II lissencephaly (HP:0007260) | 1.73242083 |
| 151 | Abnormality of the fovea (HP:0000493) | 1.73063130 |
| 152 | Hamartoma of the eye (HP:0010568) | 1.72531150 |
| 153 | Hypomagnesemia (HP:0002917) | 1.70921776 |
| 154 | Absent speech (HP:0001344) | 1.70414551 |
| 155 | Hematochezia (HP:0002573) | 1.68814777 |
| 156 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.68627135 |
| 157 | Limb dystonia (HP:0002451) | 1.68314053 |
| 158 | Attenuation of retinal blood vessels (HP:0007843) | 1.65891960 |
| 159 | Polyuria (HP:0000103) | 1.65579410 |
| 160 | Constricted visual fields (HP:0001133) | 1.64788255 |
| 161 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.63685715 |
| 162 | Long clavicles (HP:0000890) | 1.62855406 |
| 163 | Cutaneous melanoma (HP:0012056) | 1.61752035 |
| 164 | Stomach cancer (HP:0012126) | 1.61748133 |
| 165 | Hyperglycemia (HP:0003074) | 1.60814109 |
| 166 | Generalized hypopigmentation of hair (HP:0011358) | 1.60546114 |
| 167 | Male pseudohermaphroditism (HP:0000037) | 1.60469464 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.95605950 |
| 2 | CASK | 3.39942884 |
| 3 | PHKG2 | 3.27716258 |
| 4 | PHKG1 | 3.27716258 |
| 5 | OBSCN | 3.14593255 |
| 6 | NME1 | 2.90432169 |
| 7 | MST4 | 2.89677398 |
| 8 | MAP3K12 | 2.76195844 |
| 9 | MAP3K4 | 2.56165182 |
| 10 | NTRK3 | 2.51128337 |
| 11 | NUAK1 | 2.46512485 |
| 12 | PINK1 | 2.43103035 |
| 13 | TRIM28 | 2.41985061 |
| 14 | MAP4K2 | 2.38377559 |
| 15 | MAP3K9 | 2.36947445 |
| 16 | MAP2K7 | 2.23301980 |
| 17 | ACVR1B | 2.17543372 |
| 18 | ARAF | 2.00899668 |
| 19 | TXK | 1.97649383 |
| 20 | MAPK15 | 1.97447384 |
| 21 | PDK4 | 1.96414838 |
| 22 | PDK3 | 1.96414838 |
| 23 | TAOK3 | 1.95993149 |
| 24 | MAP2K4 | 1.91360980 |
| 25 | EIF2AK3 | 1.90481004 |
| 26 | EPHA4 | 1.88976191 |
| 27 | GRK1 | 1.68132047 |
| 28 | CDK19 | 1.65135082 |
| 29 | MUSK | 1.59141589 |
| 30 | EIF2AK1 | 1.53918385 |
| 31 | MINK1 | 1.49331962 |
| 32 | DAPK2 | 1.48925908 |
| 33 | DAPK1 | 1.46942491 |
| 34 | TTN | 1.43419528 |
| 35 | UHMK1 | 1.41515336 |
| 36 | BRSK2 | 1.36217595 |
| 37 | KSR2 | 1.32420754 |
| 38 | GRK5 | 1.31388176 |
| 39 | CAMK2A | 1.21699069 |
| 40 | MARK1 | 1.18052810 |
| 41 | MAPK13 | 1.17690059 |
| 42 | MAP3K6 | 1.16023613 |
| 43 | MYLK | 1.15249877 |
| 44 | MAPKAPK3 | 1.12943529 |
| 45 | NLK | 1.09280655 |
| 46 | GRK7 | 1.07026623 |
| 47 | MAP2K6 | 1.06849566 |
| 48 | PNCK | 1.06821161 |
| 49 | CAMK2B | 1.06639573 |
| 50 | RIPK4 | 1.06513670 |
| 51 | CAMK2G | 1.06099503 |
| 52 | PDK2 | 1.05949266 |
| 53 | PLK2 | 1.03200092 |
| 54 | NTRK1 | 1.02027692 |
| 55 | CAMK2D | 1.00527352 |
| 56 | IRAK1 | 0.99725689 |
| 57 | KSR1 | 0.98724005 |
| 58 | BCR | 0.97154486 |
| 59 | MKNK2 | 0.94986624 |
| 60 | FGR | 0.94696951 |
| 61 | LIMK1 | 0.94490797 |
| 62 | OXSR1 | 0.93301699 |
| 63 | WNK4 | 0.93135902 |
| 64 | PIK3CG | 0.91527132 |
| 65 | AKT3 | 0.90979664 |
| 66 | PAK3 | 0.90323017 |
| 67 | CDK5 | 0.89569995 |
| 68 | PLK3 | 0.89392786 |
| 69 | PRPF4B | 0.87338979 |
| 70 | WNK3 | 0.87262612 |
| 71 | STK16 | 0.86748589 |
| 72 | IKBKB | 0.80584449 |
| 73 | PRKCG | 0.80221964 |
| 74 | MAP3K2 | 0.79881296 |
| 75 | BMPR2 | 0.79193192 |
| 76 | BRAF | 0.79060975 |
| 77 | MAPK12 | 0.78903990 |
| 78 | TNIK | 0.78638839 |
| 79 | PRKCE | 0.77280851 |
| 80 | DYRK1A | 0.77231119 |
| 81 | MARK3 | 0.77207891 |
| 82 | PAK6 | 0.76026666 |
| 83 | FGFR2 | 0.73577213 |
| 84 | NTRK2 | 0.71400930 |
| 85 | RAF1 | 0.71153142 |
| 86 | ERBB3 | 0.70555254 |
| 87 | MAP3K13 | 0.70407605 |
| 88 | DMPK | 0.69591708 |
| 89 | PTK2B | 0.69462407 |
| 90 | FER | 0.69161398 |
| 91 | MAP3K5 | 0.67040056 |
| 92 | MAP3K11 | 0.66892891 |
| 93 | PRKCQ | 0.65307226 |
| 94 | SGK494 | 0.65233292 |
| 95 | SGK223 | 0.65233292 |
| 96 | ZAK | 0.65056268 |
| 97 | TEC | 0.64983261 |
| 98 | IRAK2 | 0.64815090 |
| 99 | SIK3 | 0.63804714 |
| 100 | LMTK2 | 0.63711641 |
| 101 | BCKDK | 0.62268678 |
| 102 | MAP2K1 | 0.61464390 |
| 103 | VRK1 | 0.61148155 |
| 104 | CSNK1G1 | 0.61116018 |
| 105 | STK24 | 0.60347365 |
| 106 | PIK3CA | 0.60263186 |
| 107 | STK39 | 0.59457498 |
| 108 | STK3 | 0.58239718 |
| 109 | INSRR | 0.57638751 |
| 110 | CDK14 | 0.57050257 |
| 111 | TGFBR2 | 0.56153470 |
| 112 | MAP3K1 | 0.55924618 |
| 113 | TLK1 | 0.54899106 |
| 114 | BMPR1B | 0.54572792 |
| 115 | PKN1 | 0.51432758 |
| 116 | CCNB1 | 0.51146417 |
| 117 | PRKACA | 0.51075930 |
| 118 | ADRBK1 | 0.50958641 |
| 119 | SGK1 | 0.50151430 |
| 120 | MAP3K7 | 0.49282175 |
| 121 | SGK2 | 0.49009044 |
| 122 | TNK2 | 0.48863463 |
| 123 | IKBKE | 0.47936528 |
| 124 | CDK18 | 0.46912966 |
| 125 | CSNK1G2 | 0.46368862 |
| 126 | CSNK1G3 | 0.45631347 |
| 127 | DYRK2 | 0.45165927 |
| 128 | YES1 | 0.44052084 |
| 129 | WEE1 | 0.43918069 |
| 130 | PRKG1 | 0.43248057 |
| 131 | PLK4 | 0.42668565 |
| 132 | CAMKK2 | 0.40302439 |
| 133 | CDK15 | 0.40195499 |
| 134 | TRPM7 | 0.39665909 |
| 135 | DYRK1B | 0.39234447 |
| 136 | TAOK2 | 0.38548481 |
| 137 | NEK1 | 0.38137460 |
| 138 | ADRBK2 | 0.37982020 |
| 139 | LATS2 | 0.36676762 |
| 140 | TGFBR1 | 0.35690786 |
| 141 | ROCK1 | 0.34819249 |
| 142 | CDK11A | 0.34776056 |
| 143 | FES | 0.33540560 |
| 144 | SYK | 0.32348429 |
| 145 | GRK6 | 0.31707944 |
| 146 | ITK | 0.30183995 |
| 147 | ABL1 | 0.30146733 |
| 148 | LYN | 0.28710438 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.04243700 |
| 2 | Parkinsons disease_Homo sapiens_hsa05012 | 3.47660198 |
| 3 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.94201220 |
| 4 | Alzheimers disease_Homo sapiens_hsa05010 | 2.83559360 |
| 5 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.82109135 |
| 6 | Nicotine addiction_Homo sapiens_hsa05033 | 2.52768589 |
| 7 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.51192592 |
| 8 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.47393837 |
| 9 | Huntingtons disease_Homo sapiens_hsa05016 | 2.30366847 |
| 10 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.99755042 |
| 11 | GABAergic synapse_Homo sapiens_hsa04727 | 1.97808773 |
| 12 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.95775013 |
| 13 | Olfactory transduction_Homo sapiens_hsa04740 | 1.92571471 |
| 14 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.90294928 |
| 15 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.85665414 |
| 16 | Circadian entrainment_Homo sapiens_hsa04713 | 1.82015051 |
| 17 | Long-term potentiation_Homo sapiens_hsa04720 | 1.76244552 |
| 18 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.73591687 |
| 19 | Morphine addiction_Homo sapiens_hsa05032 | 1.60864797 |
| 20 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.60605686 |
| 21 | Circadian rhythm_Homo sapiens_hsa04710 | 1.60117567 |
| 22 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.60053788 |
| 23 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.56747375 |
| 24 | Basal transcription factors_Homo sapiens_hsa03022 | 1.54544567 |
| 25 | Taste transduction_Homo sapiens_hsa04742 | 1.54123678 |
| 26 | Insulin secretion_Homo sapiens_hsa04911 | 1.53749638 |
| 27 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.53051812 |
| 28 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.50669000 |
| 29 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.48709291 |
| 30 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.47154500 |
| 31 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.46005305 |
| 32 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.45289615 |
| 33 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.43479380 |
| 34 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.43238130 |
| 35 | Renin secretion_Homo sapiens_hsa04924 | 1.39255676 |
| 36 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.38330796 |
| 37 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.38192203 |
| 38 | RNA degradation_Homo sapiens_hsa03018 | 1.35718155 |
| 39 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.34626317 |
| 40 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.32005599 |
| 41 | Long-term depression_Homo sapiens_hsa04730 | 1.27163973 |
| 42 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.25986956 |
| 43 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.23296901 |
| 44 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.23044083 |
| 45 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.22441871 |
| 46 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.21757241 |
| 47 | Salivary secretion_Homo sapiens_hsa04970 | 1.18889168 |
| 48 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.18343898 |
| 49 | RNA polymerase_Homo sapiens_hsa03020 | 1.17771344 |
| 50 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.16754911 |
| 51 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.13019293 |
| 52 | Legionellosis_Homo sapiens_hsa05134 | 1.12431016 |
| 53 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.11619686 |
| 54 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.11611001 |
| 55 | Peroxisome_Homo sapiens_hsa04146 | 1.11284957 |
| 56 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.09908145 |
| 57 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.07609649 |
| 58 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.05074448 |
| 59 | Cocaine addiction_Homo sapiens_hsa05030 | 1.04901179 |
| 60 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.04285571 |
| 61 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.03094863 |
| 62 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.01908490 |
| 63 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.01906570 |
| 64 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.01824360 |
| 65 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.01719494 |
| 66 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.99285792 |
| 67 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.98396905 |
| 68 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.97025608 |
| 69 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.94903341 |
| 70 | Mineral absorption_Homo sapiens_hsa04978 | 0.94149634 |
| 71 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.92666051 |
| 72 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.91233951 |
| 73 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.91120583 |
| 74 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.88244843 |
| 75 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.86423577 |
| 76 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.85234222 |
| 77 | Gap junction_Homo sapiens_hsa04540 | 0.85125452 |
| 78 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.85003703 |
| 79 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.82003503 |
| 80 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.81284346 |
| 81 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.77906754 |
| 82 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.77510146 |
| 83 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.75851692 |
| 84 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.74868837 |
| 85 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.72127254 |
| 86 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.71362810 |
| 87 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.70972676 |
| 88 | Allograft rejection_Homo sapiens_hsa05330 | 0.69970805 |
| 89 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.67163480 |
| 90 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.66244405 |
| 91 | Melanogenesis_Homo sapiens_hsa04916 | 0.65826559 |
| 92 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.62824206 |
| 93 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.62461784 |
| 94 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.62174604 |
| 95 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.61622212 |
| 96 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.61203990 |
| 97 | Carbon metabolism_Homo sapiens_hsa01200 | 0.60474208 |
| 98 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.60447726 |
| 99 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.58372587 |
| 100 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.57936174 |
| 101 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.57853766 |
| 102 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.56155506 |
| 103 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.55674529 |
| 104 | Protein export_Homo sapiens_hsa03060 | 0.54029353 |
| 105 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.53693864 |
| 106 | Purine metabolism_Homo sapiens_hsa00230 | 0.53482230 |
| 107 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.53243733 |
| 108 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.53184109 |
| 109 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.52677244 |
| 110 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.52460277 |
| 111 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.49877259 |
| 112 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.49490700 |
| 113 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.49473075 |
| 114 | Phototransduction_Homo sapiens_hsa04744 | 0.48057855 |
| 115 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.47195492 |
| 116 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.45575111 |
| 117 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.45037837 |
| 118 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.44420245 |
| 119 | Homologous recombination_Homo sapiens_hsa03440 | 0.43695716 |
| 120 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.43139724 |
| 121 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.42926998 |
| 122 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.42291096 |
| 123 | Axon guidance_Homo sapiens_hsa04360 | 0.41399017 |
| 124 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.41367664 |
| 125 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.41319827 |
| 126 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.38782265 |
| 127 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.37952129 |
| 128 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.37784503 |
| 129 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.37741814 |
| 130 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.37672870 |
| 131 | Malaria_Homo sapiens_hsa05144 | 0.37473941 |
| 132 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.37380146 |
| 133 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.36288223 |
| 134 | Retinol metabolism_Homo sapiens_hsa00830 | 0.35026282 |
| 135 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.34702729 |
| 136 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.34590988 |
| 137 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.33710201 |
| 138 | Proteasome_Homo sapiens_hsa03050 | 0.33255595 |
| 139 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.32720963 |
| 140 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.31746254 |
| 141 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.31147752 |
| 142 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.30930732 |
| 143 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.30490494 |
| 144 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.30257320 |
| 145 | Phagosome_Homo sapiens_hsa04145 | 0.28001333 |
| 146 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.27651187 |
| 147 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.27467718 |
| 148 | Measles_Homo sapiens_hsa05162 | 0.27031619 |
| 149 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.26740266 |
| 150 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.26146979 |
| 151 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.26142937 |
| 152 | Tight junction_Homo sapiens_hsa04530 | 0.25649697 |
| 153 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.25344564 |
| 154 | Metabolic pathways_Homo sapiens_hsa01100 | 0.24611527 |

